Assessing the potential of CRISPR-based gene editing for the treatment of beta-thalassemia – Complete Phd and Masters Thesis
[ad_1] Introduction: Beta-thalassemia is a genetic disorder characterized by the reduced production of hemoglobin, leading to severe anemia and other complications. Current treatment options, such as regular blood transfusions and iron chelation therapy, have limitations…
Read More